Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Net Margin (2017 - 2026)

Integra Lifesciences Holdings' Net Margin history spans 16 years, with the latest figure at 0.39% for Q4 2025.

  • On a quarterly basis, Net Margin fell 478.0% to 0.39% in Q4 2025 year-over-year; TTM through Dec 2025 was 31.58%, a 3115.0% decrease, with the full-year FY2025 number at 31.58%, down 3115.0% from a year prior.
  • Net Margin hit 0.39% in Q4 2025 for Integra Lifesciences Holdings, up from 1.34% in the prior quarter.
  • Over the last five years, Net Margin for IART hit a ceiling of 13.3% in Q4 2022 and a floor of 116.47% in Q2 2025.
  • Historically, Net Margin has averaged 0.97% across 5 years, with a median of 5.05% in 2023.
  • Biggest five-year swings in Net Margin: surged 1002bps in 2021 and later crashed -11351bps in 2025.
  • Tracing IART's Net Margin over 5 years: stood at 11.19% in 2021, then grew by 19bps to 13.3% in 2022, then plummeted by -62bps to 5.0% in 2023, then decreased by -12bps to 4.39% in 2024, then tumbled by -109bps to 0.39% in 2025.
  • Business Quant data shows Net Margin for IART at 0.39% in Q4 2025, 1.34% in Q3 2025, and 116.47% in Q2 2025.